Skip to main content
Clinical Trials/NCT02783443
NCT02783443CompletedNot Applicable

Effect General and Regional Anesthesia on Glycocalyx

University Hospital Hradec Kralove0 sites60 target enrollmentStarted: June 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Primary Endpoint
Change in Perfused Boundary Region (PBR)

Study Overview

Brief Summary

Observational study evaluating effect general or regional anaesthesia on glycocalyx by using perfused Boundary Region in sublingual microcirculation.

Detailed Description

Study II: Effect general and regional anaesthesia on GCX Hypothesis to be tested: Regional anaesthesia affects GCX less than general anaesthesia.

The aim of the study: Comparison of two anaesthesia techniques with respect to GCX.

Type of the study: Observational. Subjects: Adult patients ASA 2-3 undergoing elective total knee replacement surgery under general or regional anaesthesia. Sample size calculation (based on expected difference in PRB, alpha error I = 0,05 and study power = 0,99) = 52 patients. Investigators plan to enroll of 60 consecutive patients to reach 30 patients with each type of anaesthesia. Intervention: none. Data to be recorded and analysed: Demographics, ASA, physiologic functions (during surgery and 24 hours after surgery), fluids given, sublingual microcirculation by SDF imaging will be recorded at time points: before anaesthesia, 24 hours after anaesthesia, clinical outcome indicators, microcirculatory data and Perfused Boundary Region.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patients ASA 2-3 undergoing elective total knee replacement surgery

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in Perfused Boundary Region (PBR)

Time Frame: Change from baseline PBR at 24 hours after surgery

PBR is an indirect measure of glycocalyx thickness

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Vladimir Cerny

prof. Vladimir Cerny, MD, PhD, FCCM

University Hospital Hradec Kralove

Similar Trials